Document is current
Any future updates will be listed below
-
Authors
Foessl, Ines https://orcid.org/0000-0002-9804-8859
Dimai, Hans P.
Obermayer-Pietsch, Barbara https://orcid.org/0000-0003-3543-1807
- License Information
-
More Information
Article History
Accepted: 21 June 2023
First Online: 18 July 2023
Competing interests
: B.O.-P. declares lecture fees from Immundiagnostic Systems, Eli Lilly, Gedeon Richter, Institut Allergosan, anwerina, Merck Sharp & Dome, Roche, UCB and unrestricted research grants from CBmed, Immundiagnostic Systems, Infineon, Institut Allergosan, Kinderwunschinstitut, SelenoMed, ViennaLab and Winclove. H.P.D. declares lecture and consultancy fees from Amgen, Braincon, Daiichi-Sankyo, Eli Lilly, Gedeon Richter, Genericon, Medtronic, Merck Sharp & Dohme, Novartis, Nycomed, Sanabo, Servier, Sinapharm, Stada and UCB. I.F. was a part-time employee (Medical Oncology, Amgen Austria) during the writing of the first draft, but not thereafter, all outside of the present work.
